MYBL2 and neoplasm: Importantly, MYBL2 knockdown significantly reduced the incidence of bone metastasis (from 62.5% to 12.5%) and the number of bone metastatic lesions (from 2 to 0.25) in tumor-bearing mice (Figure 3G).